Navigation Links
PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
Date:6/4/2008

more than 20,000 industry and business leaders, scientists, and investors from more than 60 countries. The convention will address the drivers behind new medicine, processes, and other areas of the global biotechnology industry.

For more information about PAREXEL visit http://www.PAREXEL.com or Booth 1337 at the BIO convention.

About PAREXEL International

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 63 locations throughout 52 countries around the world, and has more than 7,600 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this releas
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
2. PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
3. PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
4. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
5. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
6. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
7. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
8. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
9. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
10. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
11. PAREXEL International Announces 2-For-1 Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 Demanding industrial ... Lenses engineered of synthetic Sapphire and Glass Ball Lenses, ... from Swiss Jewel Company , of Philadelphia , ... expanding and collimating the light beams without the need ... clarity and natural durability (9 mohs) make it the ...
(Date:6/18/2013)... 18, 2013 The Pistoia ... the HELM biomolecular representation standard software toolkit and ... HELM (Hierarchical Editing Language for Macromolecules) ... biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) whose ... informatics methodologies impractical or unusable. HELM solves this ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... Texas , June 18, 2013   ... ), a biopharmaceutical company focused on discovering breakthrough ... John Northcott has joined the company as ... operations. Mr. Northcott brings extensive commercial experience to ... across a variety of therapeutic areas. ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... ULURU Inc. (NYSE Amex: ... the treatment of wounds using Altrazeal(TM) along with pre-clinical and ... at the annual Society for Advance Wound Care Conference ("SAWC") ... clinical evidence and data will be presented on posters on ...
... (Nasdaq: ANDS ), a biopharmaceutical company dedicated ... the areas of hepatitis C and oncology, today reported ... ended March 31, 2009. "We have now concluded three ... HCV patients that demonstrated potent antiviral activity over three ...
... N.J., April 23 Wyeth (NYSE: WYE ... of its outstanding $2 Convertible Preferred Stock, par value ... July 15, 2009 (the "Redemption Date"). As of ... Preferred Stock outstanding.The redemption price for each share of ...
Cached Biology Technology:ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009 2Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 2Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 3Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 4Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 5Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 6Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 7Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 8Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 9Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights 10Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 2Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 3Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 4Wyeth Announces Full Redemption of $2 Convertible Preferred Stock 5
(Date:6/17/2013)... in Biochemical and Biophysical Research Communications , Saint ... new, previously unknown viruses. The technique offers the potential ... not identified a particular virus as the likely source ... approach, scientists use blood serum as a biological source ... the complete deciphering of the human genome, SLU researchers ...
(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...
(Date:6/17/2013)... . A new ... disease can be reversed with treatment. The study by researchers ... at McGill University and at Universit de Montral found that ... of mice with advanced Alzheimer,s disease (AD) recovers memory and ... Neuroinflammation in May, also suggest an underlying mechanism of ...
Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
... RNA, a tiny chemical cousin of DNA, to turn on ... a gene awake would help alleviate disease, researchers at UT ... is being developed by UT Southwestern scientists, also is providing ... that genes play in human health. , In ...
... biology, known as ‘evo-devo? is being held back because ... to illustrate key questions about evolution, argue biologists in ... subject of evo-devo, which became established almost a decade ... organisms that have been inherited from developmental biology (fruit ...
... adult mice a drug - a synthetic designed to mimic ... now able to chemically switch on PPAR-d, the master regulator ... Even when the mice are not active, turning on the ... exercise. The resulting shift in energy balance (calories in, calories ...
Cached Biology News:Novel laboratory technique nudges genes into activity 2Novel laboratory technique nudges genes into activity 3Biologists call for better choice of model organisms in 'evo-devo' 2Biologists call for better choice of model organisms in 'evo-devo' 3'Exercise pill' switches on gene that tells cells to burn fat 2
... DH-2000, except that it uses a deep-UV deuterium ... and comes with a shutter (controlled via a ... The DH-2000 Deuterium Tungsten Halogen Light ... tungsten halogen light sources in a single optical ...
... Quidel's depleted sera are specifically depleted of ... of the depleted protein, the alternative and ... are therefore ideal for the detection and ... sera have been used to assess complement ...
... Identical to the D-2000, except that it uses ... nm wavelength range and comes with a shutter ... The D-2000 Deuterium Light Source produces a ... deep-UV versions of the light source are available, ...
... is a fully automated microplate based ... labs in academia and industry. The ... Fluorescence Intensity including FRET ... including DELFIATM High-Performance Luminescence ...
Biology Products: